Author:
Scavone Cristina,Di Mauro Cristina,Ruggiero Rosanna,Bernardi Francesca Futura,Trama Ugo,Aiezza Maria Luisa,Rafaniello Concetta,Capuano Annalisa
Publisher
Springer Science and Business Media LLC
Reference79 articles.
1. Agenzia Italiana del Farmaco. Zyloric. Riassunto delle Caratteristiche del Prodotto. https://farmaci.agenziafarmaco.gov.it/aifa/servlet/PdfDownloadServlet?pdfFileName=footer_007046_021259_RCP.pdf&retry=0&sys=m0b1l3. Accessed 14 Mar 2019.
2. Chen XJ, Eirin A, Kane GC, Misra S, Textor SC, Lerman A, Lerman LO. Impact of Serum Uric Acid Levels on Outcomes following Renal Artery Revascularization in Patients with Renovascular Disease. Int J Hypertens. 2019;2019:3872065. https://doi.org/10.1155/2019/3872065.
3. Qin T, Zhou X, Wang J, Wu X, Li Y, Wang L, Huang H, Li J. Hyperuricemia and the prognosis of hypertensive patients: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2016;18:1268–78. https://doi.org/10.1111/jch.12855.
4. Weiner IM. Diuretics and other agents employed in the mobilization of edema fluid, Goodman and Gilman’s the pharmacological basis of therapeutics. New York: McGraw-Hill; 1993.
5. Choi HK, Soriano LC, Zhang Y, Rodríguez LA. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ. 2012;344:d8190. https://doi.org/10.1136/bmj.d8190.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献